Imagen de Portada

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Rameshwar S. Cheke, Prashant S. Kharkar
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Chemical Biology & Drug Design
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐f][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition
por: Balaji Dashrath Sathe, et al.
Publicado: (2024)

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
por: Jingting Zeng, et al.
Publicado: (2025)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
por: Zhiqi Lin, et al.
Publicado: (2026)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
por: Nurul Alam Inayatsyah, et al.
Publicado: (2024)

Investigation of Potential Inhibitors of N‐Myristoyltransferase in Leishmania amazonensis: A Computational and Experimental Study
por: Mariana Sant’Anna Pereira Nicolau, et al.
Publicado: (2025)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
por: Kalyani R. Thombre, et al.
Publicado: (2026)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
por: Ozge Kuyrukcu Ozturk, et al.
Publicado: (2026)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
por: Yi‐Fan Zhang, et al.
Publicado: (2024)

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast
por: Siming Wu, et al.
Publicado: (2024)

Identification and Biological Evaluation of ( 4 H ‐Thieno[3,2‐ b ]indol‐3‐yl)methanol as a Tumoricidal Scaffold for an Antineoplastic Agent
por: Shi‐Hong Zhuang, et al.
Publicado: (2025)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
por: Ayoub Boualli, et al.
Publicado: (2026)

Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents
por: Ecem Kaya‐Sezginer, et al.
Publicado: (2024)

Discovery of 1‐(Cyclopropylmethyl)‐2‐(Dibenzo[b,d]Thiophen‐2‐yl)‐1H‐Benzo[d]Imidazole‐5‐Carboxylic Acid as Orally Bioavailable EP4 Receptor Antagonist
por: Sanjay Kumar, et al.
Publicado: (2025)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
por: Ayşen Işık, et al.
Publicado: (2024)

Design, Synthesis and Biological Evaluation of Aminoalkylated Paeonol Chalcone Derivatives
por: Jia‐chen Xu, et al.
Publicado: (2026)

Design, Synthesis, and Evaluation of Bis ‐Chalcones and Bis ‐Flavones as Selective COX ‐2 Inhibitors
por: Rui Pereira, et al.
Publicado: (2026)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
por: Shiying Zhang, et al.
Publicado: (2025)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
por: Ankit Kumar Singh, et al.
Publicado: (2025)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
por: Farman Ullah, et al.
Publicado: (2025)

Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery
por: Alaa Tabaza, et al.
Publicado: (2025)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
por: Jiayi Shen, et al.
Publicado: (2025)

Discovery of Novel Oxadiazole‐Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies
por: Venkatraman Hegde, et al.
Publicado: (2025)

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
por: Hualiang Shen, et al.
Publicado: (2025)

From Synthesis to Efficacy: Synthesis, Structural Analysis, and Antiviral Activity of 5‐(Trifluoromethoxy)‐ 1 H ‐indole‐2,3‐dione 3‐Thiosemicarbazones
por: Özge Soylu‐Eter, et al.
Publicado: (2026)

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent
por: Qingxin Liu, et al.
Publicado: (2025)

Protein Kinase Inhibitors: Synthesis and Molecular Repurposing in Three‐Dimensional Cancer Models PKI
por: Vladislav Lobanov, et al.
Publicado: (2025)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
por: Vijaykumar D. Nimbarte, et al.
Publicado: (2025)

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”
por: Thiago Gonçalves dos Santos Martins
Publicado: (2024)

Discovery of novel chromone and acrylate‐based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity
por: Prashant S. Auti, et al.
Publicado: (2024)

Identification of Potential PBP2a Inhibitors Against Methicillin‐Resistant Staphylococcus aureus via Drug Repurposing and Combination Therapy
por: Fangfang Jiao, et al.
Publicado: (2025)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
por: Jiayi Shen, et al.
Publicado: (2024)

Novel Benzimidazole‐Urea Phenylalanine Hybrids as Dual‐Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation
por: Tuğçe Deniz Karaca, et al.
Publicado: (2026)

Pioneering QSAR Modeling Study of FAP ‐Targeting Radiopharmaceuticals Used in Oncology
por: Dorrin Fatehi, et al.
Publicado: (2025)

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents
por: Pınar Poyraz Yılmaz, et al.
Publicado: (2025)

Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives
por: Bing He, et al.
Publicado: (2025)

Elucidation of the Microwave‐Assisted Synthesis and Characterization of Heteronuclear Complexes of Bisbenzimidazole Derivatives and Their Biological Activities by In Vitro and In Silico Assays
por: Esra Kaplan, et al.
Publicado: (2024)

Design and Synthesis of Holu‐7, a Quinazolinone Derivative With an Active Stereo Geometry and Polar 2,4‐Dihydroxyphenyl Group, as a Selective Anticancer Agent
por: Kuo‐Chu Lai, et al.
Publicado: (2025)

In Silico Exploration of Potential Inhibitors Targeting SARS ‐ CoV ‐2 Non‐Structural Protein 15 (Nsp15): A Comprehensive Overview of Current Research
por: Behnaz Yazdani, et al.
Publicado: (2025)

Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
por: Gözde Sayar, et al.
Publicado: (2026)

Attempts to Achieve Targeted Covalent Inhibition of Hsp90 β
por: Terin D'Amico, et al.
Publicado: (2026)